7 December 2016 EMA/805050/2016 Deputy Executive Director

Agenda – Update on the implementation of EMA policy on publication of clinical data (Policy 0070) and revisions to the guidance to industry – Industry Associations Webinar 9 December 2016, 10:00 to 12:00 GMT

Chair: Noël Wathion, Deputy Executive Director, EMA Item

Topic

Name

Time

1.

Welcome and introduction (meeting logistics), including

N. Wathion

10 mins

an update on the implementation of EMA policy 0070 and background to the revision of the guidance to industry 3.

Details of changes to the guidance to industry

A-S. Henry-Eude

20 mins

4.

Discussion

All

40 mins

5.

Update on the letters to industry regarding the submission of the redaction proposal document package

6.

Next steps & close of meeting

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

F. Nuttall/S. Howard N. Wathion

10 mins

10 mins

An agency of the European Union

© European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged.

Agenda - European Medicines Agency - Europa EU

Dec 7, 2016 - publication of clinical data (Policy 0070) and revisions to the guidance to industry – Industry Associations Webinar. 9 December 2016, 10:00 to ...

62KB Sizes 3 Downloads 251 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Nov 3, 2016 - Scope: 'Optimising the development of ATMPs to meet patient needs' ... the CAT would like to discuss with company representatives in person.

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - under Article 107i of Directive 2001/83/EC, based on pharmacovigilance data. Action: For adoption of ..... manufacturing process; and 3) removal of the following missing information: special patient groups. Action: For .... analysis of

Agenda - European Medicines Agency - Europa EU
4 days ago - Meningococcal group A, C, W135 and Y conjugate vaccine - NIMENRIX (CAP) -. EMEA/H/C/002226/II/0078 . ...... Applicant: AstraZeneca AB.

Agenda - European Medicines Agency - Europa EU
Jul 31, 2017 - Human Medicines Research and Development Support Division. Agenda ... use of such prior knowledge in regulatory application dossiers, to support manufacturing and control strategies ... of accelerated access schemes.

Agenda - European Medicines Agency - Europa EU
Oct 26, 2016 - (as Web sites for social networking and microblogging) through which ... 09:10. Opening remarks. D. Haerry (PCWP)/. G. Calvo (HCPWP). 1.

Agenda - European Medicines Agency - Europa EU
Nov 27, 2017 - Some of the information contained in this agenda is considered commercially confidential or sensitive and therefore not disclosed. With regard to intended therapeutic indications or procedure scopes listed against products, it must be